Arkolith/Insider Trading/WST/Form 4

Winters Chad

VP, Chief Accounting OfficerWEST PHARMACEUTICAL SERVICES INC (WST) · full profile →Form 4 · filed Feb 20, 2025
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
4
2 non-derivative · 2 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Feb 18, 2025Option exercise(M)82$211.00$17K1K
Feb 18, 2025Tax withholding(F)28$211.00$6K1K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Feb 18, 2025Grant(A)822—$0822
Feb 18, 2025Grant(A)356—$0356

Transaction Codes

M
Option exercise / conversion
F
Shares withheld for taxes
A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001127602-25-006118) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML